Fortress Biotech
NASDAQ: FBIONew York, US · Delaware corporation · 1 known investors
Fortress Biotech is a biopharmaceutical company that acquires and advances assets across therapeutic areas including oncology, dermatology, and rare diseases, generating value through product revenue, equity holdings, and dividend and royalty income. The company operates a portfolio of marketed prescription pharmaceutical products and development programs through majority-owned subsidiaries and minority ownership positions in partner companies.
Founders & leadership
LA
Lindsay A. RosenwaldinChief Executive Officer
MS
Michael S. WeissExecutive
GA
George AvgerinosExecutive
LL
Lucy LuinChief Strategy Officer
Board
EK
Eric K. RowinskyBoard director
DK
Dov KleinBoard director
JH
Jimmie Harvey, Jr.Board director
MH
Malcolm HoenleinBoard director
JJ
J. Jay LobellBoard director
Investors · 1
Funding
SEC filings, press & company announcements$9.8M disclosed across 2 of 4 rounds · 2017–2026
- Undisclosed amountSeries BJul 2026Source ↗
▶$6.5MraisedMar 2018 · 2 investors · BiotechnologyRule 506(b)
▶$6.5MraisedMar 2018 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- J. Jay LobellDirector
- George AvgerinosExecutive Officer
- Dov KleinDirector
- Malcolm HoenleinDirector
- Jimmie Harvey, Jr.Director
- Eric K. RowinskyDirector
- Michael WeissExecutive Officer, Director
- Robyn HunterExecutive Officer
- Lindsay A. RosenwaldExecutive Officer, Director
- Offering amount
- $30M
- Amount sold
- $6.5M
- Sales commissions
- $521.4K
- Placement agents
- National Securities Corporation
- First sale
- Feb 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.3MraisedApr 2017 · 2 investors · BiotechnologyRule 506(b)
▶$3.3MraisedApr 2017 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Eric K. RowinskyDirector
- Lindsay A. RosenwaldExecutive Officer, Director
- Michael S. WeissDirector
- Dov KleinDirector
- Jimmie Harvey, Jr.Director
- Malcolm HoenleinDirector
- J. Jay LobellDirector
- George AvgerinosExecutive Officer
- Lucy LuExecutive Officer
- Amount sold
- $3.3M
- Sales commissions
- $325.4K
- Placement agents
- National Securities Corporation
- First sale
- Mar 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlap
Robinhood56 shared keywordsRobinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets. The platform serves retail investors with low barriers to entry, offering portfolio management services and market insights.
Seeking Alpha50 shared keywordsSeeking Alpha is a financial research platform offering stock analysis, market news, investment ideas, and quantitative ratings across asset classes, drawing on a large community of contributing analysts. It serves individual and professional investors seeking research and data-driven insight on stocks and markets.
Companies competing with Fortress Biotech for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Fortress Biotech posts $137.8M profit in H1 2026 | FBIO Quarterly Report (10-Q)stocktitan.net · Aug 2026Frequently asked questions
- What does Fortress Biotech do?
- Fortress Biotech is a biopharmaceutical company that acquires and advances assets across therapeutic areas including oncology, dermatology, and rare diseases, generating value through product revenue, equity holdings, and dividend and royalty income. The company operates a portfolio of marketed prescription pharmaceutical products and development programs through majority-owned subsidiaries and minority ownership positions in partner companies.
- Who are Fortress Biotech's investors?
- Fortress Biotech's investors include Frazier Life Sciences.
- How much funding has Fortress Biotech raised?
- Fortress Biotech has disclosed $9.8M raised across 2 of its 4 known rounds.
- Where is Fortress Biotech headquartered?
- Fortress Biotech is headquartered in New York, US.